BCL9 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5100196-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5100196 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
BCL9
Classification
Polyclonal
Conjugate
Unconjugated
Gene
BCL9
Gene Alias
2610202E01Rik; 8030475K17Rik; A330041G23Rik; B cell CLL/lymphoma 9; B-cell CLL/lymphoma 9; B-cell CLL/lymphoma 9 protein; B-cell lymphoma 9 protein; BCL9; bcl-9; Gm130; LGS; nuclear co-factor of beta-catenin signalling; protein legless homolog
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
607, 77578
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
O00512, Q9D219
Gene Symbols
BCL9
Immunogen
A synthesized peptide derived from human BCL9(Accession O00512), corresponding to amino acid residues I860-V910.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total BCL9
- BCL9 is involved in signal transduction through the Wnt pathway
- It promotes beta-catenin's transcriptional activity
- BCL9 is associated with B-cell acute lymphoblastic leukemia
- The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.